Prescribing data

Prescribing data

There are currently no medicines optimisation key therapeutic topic (MO KTT) prescribing comparators for this topic. The development of a suitable comparator is currently being explored by the NHS England Medicines Optimisation Intelligence Group[2]. The National dementia and antipsychotic prescribing audit from 2012 suggests that there has been an encouraging overall reduction in the proportion of people with dementia being prescribed antipsychotics in recent years. See the National Dementia and Antipsychotic Prescribing Audit website for more details.

Based on data from 46% of GP practices across England, the audit found that the number of people newly diagnosed each year with dementia increased by 68% in relative terms from 2006 to 2011. However, there was a decrease of 10.25 percentage points in the number of people with dementia receiving prescriptions for antipsychotic medication over that time (from 17.05% in 2006 to 6.80% of people in 2011, a 60% reduction in relative terms). The proportion of people receiving a prescription for an antipsychotic within a year of being diagnosed with dementia also decreased by 9.79 percentage points from 2006 to 2011 (from 14.25% to 4.46%, a 69% reduction in relative terms). Nevertheless, although reductions in prescribing rates were seen across all geographical areas of England, there was still considerable variation in the percentage of people diagnosed with dementia prescribed an antipsychotic.

The Prescribing Observatory for Mental Health-UK (POMH-UK) audit Prescribing antipsychotic medication for people with dementia suggests that the prevalence of antipsychotic use in mental health trusts or healthcare organisations for behavioural and psychological symptoms of dementia decreased between 2011 and 2012 (by 23%) and this decrease was maintained in 2016 (19% down from 2011).



[2] For details of any update to the comparators refer to the NHS Digital website and the Information Services Portal, Business Services Authority.